COMMUNIQUÉS West-GlobeNewswire

-
GENFIT : ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018 - AVAILABILITY OF PREPARATORY DOCUMENTS
09/05/2018 - 17:56 -
GENFIT : ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 15 JUIN 2018 - MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
09/05/2018 - 17:56 -
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
09/05/2018 - 17:31 -
ReWalk Robotics to Report First Quarter 2018 Financial Results on May 10, 2018
09/05/2018 - 17:30 -
Horizon Discovery Group plc Acknowledges Statement by Abcam
09/05/2018 - 16:52 -
Huron Digital Pathology Collaborates with UPMC on Artificial Intelligence-based Image Search, Presents Pathologist-centric Approach to Image Retrieval at Pathology Informatics Summit in Pittsburgh
09/05/2018 - 16:39 -
Intrommune Therapeutics Announces Crowdfunding Financing Campaign to Support Food Allergy Treatment Research
09/05/2018 - 16:36 -
Scapa Healthcare Introduces New Hydrocolloid Offerings for Ostomy Applications
09/05/2018 - 16:15 -
Vistin Pharma ASA : Employee share options
09/05/2018 - 16:13 -
Gail Miller Chosen New Board Chair Of Intermountain Healthcare
09/05/2018 - 15:33 -
ORYZON Reports Financial Results and Corporate Update for the 1st Quarter 2018
09/05/2018 - 15:33 -
Probiodrug AG to hold its Ordinary General Meeting of Shareholders on 21 June 2018
09/05/2018 - 15:05 -
Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use
09/05/2018 - 15:01 -
Indiana Family and Social Services Administration Selects Cerner to Implement Electronic Health Record
09/05/2018 - 15:01 -
MannKind and Cipla Enter an Exclusive Marketing and Distribution Agreement for Afrezza® in India
09/05/2018 - 15:00 -
REVA Medical Reports First Quarter 2018 Financial Results
09/05/2018 - 15:00 -
Mismatched Patient Records: An Under-Recognized and Growing Problem for Most Hospitals, Imprivata CIO Survey Finds
09/05/2018 - 15:00 -
Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2018 and Host Conference Call on May 14
09/05/2018 - 14:30 -
resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly
09/05/2018 - 14:30
Pages